Cerrahpasa Medical Journal

OCT 22, 2026 · JOURNAL ARTICLE

Real-World Outcomes of 177Lu-PSMA-617 Radioligand Therapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer

Cerrahpasa Medical Journal

Objective: Among recently developed treatment strategies for advanced prostate cancer, 177Lu-PSMA-617–based radioligand therapy has shown considerable clinical potential in patient

SEP 8, 2026 · JOURNAL ARTICLE

Progression Patterns as Determinants of Post-Progression Survival in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors

Cerrahpasa Medical Journal

Retrospective single-center study of 87 patients identifying progression patterns as prognostic factors for post-progression survival in CDK4/6-inhibitor-treated HR+/HER2− metastatic breast cancer, with statistically significant hazard ratios for visceral and liver progression but limited by design and sample size.

AUG 14, 2026 · JOURNAL ARTICLE

Effect of Maintenance Anti-EGFR Therapy on Survival in RAS Wild-Type Metastatic Colorectal Cancer: Real-World Data

Cerrahpasa Medical Journal

Single-center retrospective study with modest sample size (n=37), selection bias acknowledged by authors, and OS finding not matched by PFS significance; needs prospective confirmation.